| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, April 19, 2022 7:55:25 PM
Denis Heady, works at Cedars Sinai
https://www.linkedin.com/in/denise-heady-ma-8606b527/
I note this very old dispute with Cedars Sinai, from December 9, 2011:
https://nwbio.com/northwest-bio-reaffirms-its-freedom-to-operate-refutes-other-parties-misleading-patent-assertions-2/
It is interesting that you blocked her contact information, why would you need to do that if she is the UCLA Johnsoon Cancer Center Media relations contact? And were you writing to her indicating you were from the Boston Globe as Senior Writer, National Biotech?
If you read carefully, Heady's description of the origin of the vaccine, and the order of where it was developed and by whom, I think a deep dive into original documents will show that she was confused. And ATL-DC is not a different vaccine, and I have evidence of that from Dr. Liau directly. So please go ahead. Fire away. Looking forward to your really going for it this time.
It will be interesting to see what the fallout will be.
https://www.linkedin.com/in/denise-heady-ma-8606b527/
I note this very old dispute with Cedars Sinai, from December 9, 2011:
https://nwbio.com/northwest-bio-reaffirms-its-freedom-to-operate-refutes-other-parties-misleading-patent-assertions-2/
It is interesting that you blocked her contact information, why would you need to do that if she is the UCLA Johnsoon Cancer Center Media relations contact? And were you writing to her indicating you were from the Boston Globe as Senior Writer, National Biotech?
If you read carefully, Heady's description of the origin of the vaccine, and the order of where it was developed and by whom, I think a deep dive into original documents will show that she was confused. And ATL-DC is not a different vaccine, and I have evidence of that from Dr. Liau directly. So please go ahead. Fire away. Looking forward to your really going for it this time.
It will be interesting to see what the fallout will be.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
